Digital biomarkers

What do they mean for your business?

Vaishali Kamat & Jaquie Finn

2

BIOMARKERS

3

DIGITAL BIOMARKERS

4

WHY NOW? DATA AVAILABLE

5

WHY NOW? MEASURE OUTCOMES

CMS expects 50% of all payments to be via alternative models by 2018

6

IMPROVE CLINICAL TRIALS

7

MANAGE CHRONIC DISEASE

8

OPTIMAL BALANCE

Business

model

Market

proposition

Science,

technology

& systems

9

ITERATIVE PROCESS

THINK BUILD LAUNCH

LEARN

10

IMPROVE ENGAGEMENT

A direct relationship with the patient/ user is feasible and can be productive

11

KEEP IT SIMPLE FOR THE CLINICIANS

12

GET TO MARKET QUICKLY

Build brand awareness

and improve patient

engagement

Launch with a

Minimum Viable

Product (MVP) & start

gathering data

Work toward a more robust

solution that can give the required

claims for the longer term.

13

PROVIDE REAL VALUE FROM THE DATA

Data Feed

Valu

e

Descriptive

Analytics

Diagnostic

Analytics

Predictive

Analytics

Prescriptive

Analytics

What

happened?

Why did it

happened?

What will

happen?

How can we make it

happen? Nudge

behaviour

Provide

Information

14

DIGITAL BIOMARKERS – Example

15

DIGITAL BIOMARKERS – Example

16

TIPS FOR SUCCESS – Strategy

Why? For who?

When? Money?

Market?

What?

17

TIPS FOR SUCCESS – Partners

18

TIPS FOR SUCCESS - Start Now

?

The contents of this presentation are commercially confidential

and the proprietary information of Cambridge Consultants

© 2016 Cambridge Consultants Ltd. All rights reserved.

UK

Cambridge Consultants is part of the Altran group, a global

leader in Innovation. www.Altran.com

www.CambridgeConsultants.com

USA SINGAPORE JAPAN

Registered No. 1036296 England